ANAHIT.CARE

Team and governance

A platform driven by a medical, technological and international vision

ANAHIT.CARE brings together two complementary strengths: a product vision shaped by digital field experience and French-Armenian medical leadership able to anchor the project in rigor, caution and credibility.

Portrait of Guillaume Movassagiyan Morvan
Co-founder & CEO

Guillaume Movassagiyan Morvan

Co-founder and CEO of ANI HEALTH SAS, Guillaume leads the product, technology and operational vision of ANAHIT.CARE.

His background combines a rare dual culture: early training at the Institut d’Informatique Appliquée in business information systems and software analysis/programming, followed by business school, and recent technical upskilling through a Full Stack Python Application Developer Bachelor at HETIC / Studi, French Bac+3 / Bac+4 level.

For more than twenty years, he has worked across IT, business software, SaaS, ERP systems, digital transformation, digital health and entrepreneurship.

Before ANAHIT.CARE, he co-founded Saaba by G2 CARE, an e-health platform connecting family caregivers of elderly people with the wider ecosystem of professionals involved in dependency care, incubated at Marseille Innovation.

His role within ANAHIT.CARE is to turn an international healthcare ambition into a robust, readable, compliant and scalable platform able to connect patients, doctors, clinics and partners within a trusted journey.

Portrait of Professor Arsène Mekinian
Co-founder & medical leadership

Professor Arsène Mekinian

Co-founder of ANAHIT.CARE, Professor Arsène Mekinian is a Professor of Internal Medicine at the Faculty of Health, Sorbonne University, and a hospital practitioner in the Department of Internal Medicine at Saint-Antoine Hospital / AP-HP.

He is involved in several reference and competence centers: CREAK, CeRéMAIA, FAI²R and CERECAI, covering bradykinin-mediated angioedema, autoimmune diseases, adult autoimmune cytopenias and complex care pathways.

His research focuses in particular on unexplained early infertility, recurrent pregnancy loss, recurrent implantation failure, inflammatory placental diseases such as chronic intervillitis, and antiphospholipid syndrome. He coordinates the national FALCO registry and the therapeutic trials FACIL2, CERTIFY and HYDROAPS.

As President of the French MINHEMON group and President of the NGO Santé Arménie, he has been deeply involved for years in strengthening medical, scientific, hospital and institutional bridges between France, Europe and Armenia.

His scientific publications include reference work on antiphospholipid syndrome, massive perivillous fibrin deposition, chronic villitis, recurrent implantation failure and immunomodulation in unexplained recurrent miscarriage.

Within ANAHIT.CARE, he brings medical authority, institutional credibility and Armenian roots to help build a demanding, cautious and quality-driven international healthcare project.

Execution background

A profile able to connect product vision, technology and field reality

ANAHIT.CARE is built on experience at the crossroads of software development, SaaS, digital health, field usage and entrepreneurial execution.

Tech & business

Technology and business education

Trained at the Institut d’Informatique Appliquée in business information systems and software analysis/programming, then in business school, Guillaume combines two perspectives: understanding how a technical system works and turning it into an operational business model.

Full stack

Full stack expertise

He recently strengthened his technical foundation through a Full Stack Python Application Developer Bachelor at HETIC / Studi, French RNCP level 6, covering digital solution design, APIs, databases, development, testing, agile methods and solution management.

Saaba by G2 CARE

Health and social care platform experience

Before ANAHIT.CARE, he co-founded Saaba by G2 CARE, an e-health platform connecting family caregivers of elderly people with the wider ecosystem of professionals involved in dependency care. This experience gave him practical insight into sensitive journeys, trusted networks and multi-actor platforms.

Vision

Organizing trust around the international healthcare journey

ANAHIT.CARE is built on a simple conviction: medical tourism cannot rely on opacity, improvisation or scattered intermediaries. It must become a readable, secure, documented and coordinated journey.

Field

A product born from the field

ANAHIT.CARE is not designed as a simple showcase website. The platform starts from an operational reality: international care journeys are often fragmented, unclear and insufficiently structured.

Product

Technology execution

The project targets a robust architecture: partner onboarding, strict roles, controlled documents, booking, B2B subscriptions, logging and compliance for sensitive journeys.

Trust

A human ambition

Technology only creates value when it organizes trust: for patients, doctors, clinics, partners and investors.

Ecosystem

Medical partners, stay partners and strategic supporters

ANAHIT.CARE is not positioned as a simple directory. The platform aims to bring together a selected network able to support patient journey quality and execution credibility.

Healthcare

Medical partners

Clinics, specialist doctors and private practices may be integrated through onboarding, document verification and administrative validation before any public visibility.

Stay

Stay partners

Agencies, hotels, transport providers, restaurants, guides and tourism partners may support selected logistical aspects of the patient journey, without a complex marketplace in the MVP phase.

Capital

Investors and supporters

ANAHIT.CARE is progressively building an ecosystem of private investors, strategic supporters and institutional relays to consolidate its development.

Press and recognition

ANAHIT.CARE featured in Fusions & Acquisitions Magazine

ANAHIT.CARE’s presence in a special issue dedicated to investment in Armenia strengthens the project’s institutional credibility and its positioning within an economic, medical and international dynamic.

Press

Fusions & Acquisitions Magazine

ANAHIT.CARE is featured in the special issue “Invest in Armenia” of Fusions & Acquisitions Magazine, a publication focused on corporate transactions and investment.

Healthcare

Healthcare and investment article

The article authored by Professor Arsène Mekinian presents Armenia as a healthcare system in transformation and positions ANAHIT.CARE as a digital response to visibility, standardization and trust challenges.

Investors

Credibility signal

This editorial exposure places ANAHIT.CARE within a broader ecosystem: investment, healthcare, diaspora, Armenian market structuring and international cooperation.

Public sources

Verifiable institutional and scientific references

Professor Arsène Mekinian’s medical background is supported by public sources: Sorbonne University, AP-HP, FAI2R, Orphanet, PubMed publications, clinical trials and open professional articles. These references reinforce ANAHIT.CARE’s medical and institutional credibility.

Press

ANAHIT.CARE — Fusions & Acquisitions Magazine

“Invest in Armenia” special issue of Fusions & Acquisitions Magazine, featuring ANAHIT.CARE and Professor Arsène Mekinian in the context of Armenia’s healthcare system transformation.

Open source ↗
University

Sorbonne University profile

Public academic profile: Professor of Internal Medicine at Sorbonne University Faculty of Health and hospital practitioner at Saint-Antoine Hospital, with research focused on unexplained infertility, implantation failures, inflammatory placental disorders and antiphospholipid syndrome.

Open source ↗
AP-HP

AP-HP profile

Institutional AP-HP profile of Professor Arsène Mekinian, attached to the Internal Medicine department at Saint-Antoine Hospital.

Open source ↗
Hospital

Saint-Antoine consultation — AP-HP

Internal medicine consultation covering autoimmune diseases, pregnancy and autoimmunity, cytopenias and autoimmune conditions at Saint-Antoine Hospital.

Open source ↗
Rare diseases

FAI2R — CeRéMAIA centre

Reference centre for autoinflammatory diseases and inflammatory amyloidosis, constitutive site A. Mekinian.

Open source ↗
Orphanet

Orphanet — Clinical expert

Orphanet profile of Dr Arsène Mekinian: clinical expert, expert centre coordinator and principal investigator of clinical trials.

Open source ↗
Fertility

Gyneco Online — Recurrent miscarriage

Professional article: “Fausses couches à répétition : une nouvelle approche”, published in January 2022.

Open source ↗
Clinical trial

FaCIL-2 trial — SNFMI

Presentation of the FaCIL-2 trial on low-dose interleukin-2 in women with unexplained recurrent early pregnancy loss.

Open source ↗
PNDS

Cogan syndrome PNDS — FAI2R

French national diagnosis and care protocol for Cogan syndrome, coordinated by Professor Arsène Mekinian.

Open source ↗
PubMed

PubMed — Antiphospholipid syndrome

Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study. RMD Open, 2023.

Open source ↗
PubMed

PubMed — Massive perivillous fibrin deposition

Massive perivillous fibrin deposition: diagnosis, obstetrical features, and treatment. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2024.

Open source ↗
PubMed

PubMed — Chronic villitis

Chronic Villitis of unknown etiology: obstetrical features, outcome and treatment. Journal of Reproductive Immunology, 2021.

Open source ↗
PubMed

PubMed — Recurrent implantation failure

Unexplained recurrent implantation failures: predictive factors of pregnancy and therapeutic management from a French multicentre study. Journal of Reproductive Immunology, 2021.

Open source ↗
PubMed

PubMed — Hydroxychloroquine and obstetrical APS

The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study.

Open source ↗
PubMed

PubMed — Takayasu arteritis

Efficacy of tocilizumab in Takayasu arteritis: multicentre work on systemic inflammatory and autoimmune diseases.

Open source ↗

Execution principles

A project built with caution, compliance and traceability

The MVP phase must remain realistic: it demonstrates the value of the model without promising out-of-scope services or automating sensitive medical decisions.

Clear framework

Controlled matching

The platform facilitates matching between patients and professionals without replacing doctors, without automatic diagnosis and without handling medical emergencies.

Quality

Progressive selection

Partners are presented according to their validation status. The network is built progressively, prioritising execution quality over volume.

Compliance

Traceability and compliance

Access rights, sensitive documents and critical actions must be controlled, logged and limited according to the principle of least privilege.